ANXA6 and Patent ductus arteriosus: High ANXA6 expression has been associated with a poor survival in PDA, and ANXA6 levels in circulating extracellular vesicles (EVs) postulated as a diagnostic and prognostic biomarker in PDA (Leca et al., 2016).